Edmond de Rothschild Holding’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Edmond de Rothschild Holding’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,500	Closed	-$101K	–	605
2019 Q2	$101K	Hold	10,500	–	–	﹤0.01%	417
2019 Q1	$281K	Buy	10,500 +5,000	+91%	+$127K	0.01%	345
2018 Q4	$124K	Hold	5,500	–	–	﹤0.01%	445
2018 Q3	$304K	Hold	5,500	–	–	0.01%	395
2018 Q2	$393K	Buy	5,500 +3,500	+175%	+$247K	0.01%	361
2018 Q1	$123K	Buy	+2,000	New	+$176K	﹤0.01%	540

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Edmond de Rothschild Holding's TTPH Position: Q3 2019 in Review

Edmond de Rothschild Holding sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 10,500 shares — an estimated $101K sold.

Edmond de Rothschild Holding first reported a position in TTPH in Q1 2018 and held it in 6 quarters. The position peaked at $393K in Q2 2018. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

Edmond de Rothschild Holding reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Edmond de Rothschild Holding sold 10,500 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $101K.
Edmond de Rothschild Holding first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2018 and held it in 6 quarters.
Edmond de Rothschild Holding's Tetraphase Pharmaceuticals, Inc. position peaked at $393K in Q2 2018.
26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2019, filed 14 Nov 2019.